How Can Clinical Trials Improve Diversity? CTM’s Cara Brant Explains
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
How Do You Know If a Clinical Trial Is Right for You?
For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...
US Clinical Trials Market Set for Strong Growth by 2029, Driven by Technological Advances and Rising Demand for Personalized Medicine
The "Clinical Trials Market in the US 2025-2029" report has been added to ResearchAndMarkets.com's offering. The clinical trials market in the United States is poised for significant expansion with an ...
Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Global study identifies markers for the five clinical stages of Parkinson's disease
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
Thyroid Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, Companies by DelveInsight
Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the ...
FierceBiotech11d
Pliant pauses phase 2 lung fibrosis trial on advice of safety committee
Pliant Therapeutics has pumped the breaks on a mid-stage trial of its lead liver disease drug on the advice of its safety ...
ORYZON Announces Journal Publication of Final Phase IIa REIMAGINE Results with Vafidemstat in Psychiatry and Clinical Neurosciences
The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality ...
Daily Herald5d
Elk Grove hospital hosts trials on potential new Alzheimer’s treatments
More than a decade after hosting clinical trials for two medications now commonly used to slow the progression of Alzheimer’s ...